Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data

doi:10.3748/wjg.v23.i44.7818

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 44

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9314)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

456

WORD

201

HTML

4859

Figures (1-5)

261

Tables (1-3)

187

Sum=5964

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

777

Download

836

Sum=1613

Publishing Process of This Article

Item

Count

Browse

807

Download

930

Sum=1737

Nov 28, 2017 (publication date) through Jul 18, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Nov 28, 2017; 23(44): 7818-7829
Published online Nov 28, 2017. doi: 10.3748/wjg.v23.i44.7818

Table 2 Disease-free survival analysis of clinicopathological data and percentage genome change of 120 patients with hepatocellular carcinoma

Clinicopathological factor	Log-rank test, P value	Cox regression analysis, P value	HR (95%CI)
Age (yr), ≤ 49 (22.5%) vs > 49 (77.5%)	0.004^a	0.169	0.674 (0.384-1.183)
Sex (M/F), M (81.7%) vs F (19.3%)	0.146
Tumor size (cm), ≤ 4.5 (69.2%) vs > 4.5 (30.8%)	0.001^a	0.012^a	1.959 (1.160-3.309)
Satellite lesions (%), Yes (7.5%) vs No (92.5%)	0.088	0.013^a	2.900 (1255-6.702)
Vascular invasion (%), Yes (28.3%) vs No (71.7%)	0.240
Grading I, II, III, IV (%), III & IV (43.3%) vs I & II (56.7%)	0.004^a	0.063	1.626 (0.974-2.717)
Margin < 0.5 cm (%), ≤ 0.5 cm (47.5%) vs > 0.5 cm (52.5%)	0.210
Cirrhosis (%), Yes (54.2%) vs No (45.8%)	0.258
AFP (100 ng/mL), £100 (77.5%) vs > 100 (22.5%)	0.006^a	0.462	1.244 (0.695-2.227)
Alkaline phosphatase (120 U/L), ≤ 120 (88.3%) vs > 120 (11.7%)	0.016^a	0.042^a	1.976 (1.025-3.808)
Staging I/II, II (40.0%) vs I (60.0%)	0.104
Percentage genome changed (60%), ≥ 60% (7.5%) vs < 60% (92.5%)	0.004^a	0.031^a	2.346 (1.080-5.097)

^aP < 0.05, statistically significant. AFP: α-fetoprotein; HCC: Hepatocellular carcinoma; HR: Hazard ratio; CI: Confidence interval; M: Male; F: Female.

Citation: Yu MC, Lee CW, Lee YS, Lian JH, Tsai CL, Liu YP, Wu CH, Tsai CN. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data. World J Gastroenterol 2017; 23(44): 7818-7829
URL: https://www.wjgnet.com/1007-9327/full/v23/i44/7818.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i44.7818